These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 18675289)
1. Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret. Warneck JB; Cheng FH; Barnes MJ; Mills JS; Montana JG; Naylor RJ; Ngan MP; Wai MK; Daiss JO; Tacke R; Rudd JA Toxicol Appl Pharmacol; 2008 Nov; 232(3):369-75. PubMed ID: 18675289 [TBL] [Abstract][Full Text] [Related]
2. Repeated administration of the 5-HT3 receptor antagonist granisetron reduces the incidence of delayed cisplatin-induced emesis in the piglet. Grélot L; Le Stunff H; Milano S; Blower PR; Romain D J Pharmacol Exp Ther; 1996 Oct; 279(1):255-61. PubMed ID: 8859001 [TBL] [Abstract][Full Text] [Related]
3. Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs. Yamakuni H; Sawai H; Maeda Y; Imazumi K; Sakuma H; Matsuo M; Mutoh S; Seki J J Pharmacol Exp Ther; 2000 Mar; 292(3):1002-7. PubMed ID: 10688616 [TBL] [Abstract][Full Text] [Related]
4. Automated analysis of delayed emesis in the telemetered ferret: detection of synergistic effects of aprepitant and ondansetron. Goineau S; Guillaume P; Barrais L; Castagné V Fundam Clin Pharmacol; 2014 Dec; 28(6):643-51. PubMed ID: 24750138 [TBL] [Abstract][Full Text] [Related]
5. The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret. Singh L; Field MJ; Hughes J; Kuo BS; Suman-Chauhan N; Tuladhar BR; Wright DS; Naylor RJ Eur J Pharmacol; 1997 Feb; 321(2):209-16. PubMed ID: 9063690 [TBL] [Abstract][Full Text] [Related]
6. The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials. Warr DG; Grunberg SM; Gralla RJ; Hesketh PJ; Roila F; Wit Rd; Carides AD; Taylor A; Evans JK; Horgan KJ Eur J Cancer; 2005 Jun; 41(9):1278-85. PubMed ID: 15939263 [TBL] [Abstract][Full Text] [Related]
7. DAT-582, a novel serotonin3 receptor antagonist, is a potent and long-lasting antiemetic agent in the ferret and dog. Yoshida N; Omoya H; Ito T J Pharmacol Exp Ther; 1992 Mar; 260(3):1159-65. PubMed ID: 1532032 [TBL] [Abstract][Full Text] [Related]
8. The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets. Tattersall FD; Rycroft W; Cumberbatch M; Mason G; Tye S; Williamson DJ; Hale JJ; Mills SG; Finke PE; MacCoss M; Sadowski S; Ber E; Cascieri M; Hill RG; MacIntyre DE; Hargreaves RJ Neuropharmacology; 2000 Feb; 39(4):652-63. PubMed ID: 10728886 [TBL] [Abstract][Full Text] [Related]
9. Olvanil: a non-pungent TRPV1 activator has anti-emetic properties in the ferret. Chu KM; Ngan MP; Wai MK; Yeung CK; Andrews PL; Percie du Sert N; Rudd JA Neuropharmacology; 2010 Feb; 58(2):383-91. PubMed ID: 19825380 [TBL] [Abstract][Full Text] [Related]
10. Action of ondansetron and CP-99,994 to modify behavior and antagonize cisplatin-induced emesis in the ferret. Lau AH; Kan KK; Lai HW; Ngan MP; Rudd JA; Wai MK; Yew DT Eur J Pharmacol; 2005 Jan; 506(3):241-7. PubMed ID: 15627434 [TBL] [Abstract][Full Text] [Related]
11. An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret. Rudd JA; Naylor RJ Br J Pharmacol; 1996 May; 118(2):209-14. PubMed ID: 8735616 [TBL] [Abstract][Full Text] [Related]
12. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy. Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140 [TBL] [Abstract][Full Text] [Related]
13. Antiemetic effect of a potent and selective neurokinin-1 receptor antagonist, FK886, on cisplatin-induced acute and delayed emesis in ferrets. Furukawa TY; Nakayama H; Imazumi K; Yamakuni H; Takeshita K; Matsuo M; Manda T; Uchida W Biol Pharm Bull; 2014; 37(2):232-8. PubMed ID: 24492720 [TBL] [Abstract][Full Text] [Related]
14. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting. Voravud N; Sriuranpong V J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975 [TBL] [Abstract][Full Text] [Related]
15. The delayed phase of cisplatin-induced emesis is mediated by the area postrema and not the abdominal visceral innervation in the ferret. Percie du Sert N; Rudd JA; Moss R; Andrews PL Neurosci Lett; 2009 Nov; 465(1):16-20. PubMed ID: 19733218 [TBL] [Abstract][Full Text] [Related]
16. Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods. Mahesh R; Perumal RV; Pandi PV Pharmazie; 2005 Feb; 60(2):83-96. PubMed ID: 15739895 [TBL] [Abstract][Full Text] [Related]
17. Neuropharmacology of emesis in relation to clinical response. Costall B; Naylor RJ Br J Cancer Suppl; 1992 Dec; 19():S2-7; discussion S7-8. PubMed ID: 1467196 [TBL] [Abstract][Full Text] [Related]
18. Comparison of three preclinical models for nausea and vomiting assessment. Goineau S; Castagné V J Pharmacol Toxicol Methods; 2016; 82():45-53. PubMed ID: 27477617 [TBL] [Abstract][Full Text] [Related]
19. Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin. Rudd JA; Ngan MP; Wai MK; King AG; Witherington J; Andrews PL; Sanger GJ Neurosci Lett; 2006 Jan; 392(1-2):79-83. PubMed ID: 16182445 [TBL] [Abstract][Full Text] [Related]
20. Action of anti-tussive drugs on the emetic reflex of Suncus murinus (house musk shrew). Chan SW; Rudd JA; Lin G; Li P Eur J Pharmacol; 2007 Mar; 559(2-3):196-201. PubMed ID: 17254564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]